Analyze Diet
Journal of veterinary internal medicine2024; doi: 10.1111/jvim.16976

The efficacy of N-acetylcysteine in decreasing airway inflammation and mucus accumulation in horses with 18 hours of head confinement.

Abstract: During transportation many horses develop post-transportation infection, which can be life-threatening and end their sport career. Preventing mucus accumulation and inflammation during transportation is vital, emphasizing the need for effective strategies to enhance overall horse health welfare. Objective: Assess the impact of N-acetylcysteine (NAC) on mucus accumulation and inflammation in horses subjected to 18 hours of head confinement. Methods: Six healthy crossbred horses, 5.3 ± 2.1 years of age and weighing 387 ± 30 kg. Methods: Prospective placebo-controlled cross-over design study. The horses' heads were restrained in their stalls for a period of 18 hours. They were studied under 4 conditions: Not confined (NC): before head confinement, placebo (P), and confined head (CH): 18 hours of head confinement without treatment, and N-Acetylcysteine (NAC): 18 hours of head confinement treated with NAC before confinement (15 mg/kg/day NAC PO for 3 days). Bronchoalveolar lavage (BAL) was performed in each condition. Mucus accumulation along the trachea was evaluated by endoscopy. Results: Endoscopic scores were significantly different between CH and other conditions, whereas no significant differences were found among NC, P, and NAC. The BAL cell count (34 291 ± 2624 cells/μL), neutrophil and lymphocyte count (18 601 ± 3193 cells/μL and 3337.4 ± 593 cells/μL, respectively) in CH were significantly higher compared to NAC. Neutrophil percentage was significantly higher in CH (53.8 ± 8%) compared to horses that received NAC (20.08 ± 8%). Conversely, in comparison to NAC (66.33 ± 9%), the percentage of macrophages was significantly lower in CH (35.7 ± 10%). Conclusions: N-acetylcysteine was found to significantly decrease mucus accumulation and inflammatory cell counts in horses with head confinement.
Publication Date: 2024-01-18 PubMed ID: 38236790DOI: 10.1111/jvim.16976Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research explored the effectiveness of a substance called N-acetylcysteine (NAC) in reducing mucus build-up and inflammation in horses held under head confinement for 18 hours. Such conditions often exist during horse transportation and can lead to post-transport infections, potentially jeopardising the health and careers of sport horses.

Methodology

  • Six healthy crossbred horses, aged around 5.3 years and averaging 387 kg, participated in a prospective placebo-controlled crossover study.
  • The horses’ heads were confined in their stalls for 18 hours during which they were studied under four conditions: no confinement (NC), placebo (P), confinement with no treatment (CH), and confinement with NAC treatment (15 mg/kg/day for 3 days before confinement).
  • A procedure called a bronchoalveolar lavage (BAL) was performed in each condition, and mucus along the trachea was evaluated by endoscopy.

Results

  • Endoscopic results showed significant differences between CH and the other three conditions. However, no significant differences were depicted among NC, P, and NAC groups.
  • BAL cell counts, neutrophil and lymphocyte counts, were considerably higher in the CH group compared to the NAC group.
  • Neutrophil percentage was also significantly higher in CH compared to horses treated with NAC.
  • Inversely, the percentage of macrophages, an essential cell type in the immune response, was noticeably lower in CH compared to the NAC treated horses.

Conclusion

  • The study concluded that N-acetylcysteine significantly decreased mucus accumulation and inflammatory cell counts in horses held under head confinement.
  • This suggests that NAC could be a beneficial treatment in improving horse welfare during transportation or other scenarios involving extended head confinement.

Cite This Article

APA
Tavanaeimanesh H, Alinia Z, Sadeghian Chaleshtori S, Moosavian H, Mohebi Z, Daneshi M. (2024). The efficacy of N-acetylcysteine in decreasing airway inflammation and mucus accumulation in horses with 18 hours of head confinement. J Vet Intern Med. https://doi.org/10.1111/jvim.16976

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English

Researcher Affiliations

Tavanaeimanesh, Hamid
  • Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Alinia, Zahra
  • Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Sadeghian Chaleshtori, Sirous
  • Department of Internal Medicine, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Moosavian, Hamidreza
  • Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran.
Mohebi, Zeinab
  • Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Daneshi, Mojtaba
  • Department of Animal Science, North Dakota State University, Fargo, North Dakota, USA.

References

This article includes 29 references
  1. Raidal SL, Bailey GD, Love DN. Inflammation and increased numbers of bacteria in the lower respiratory tract of horses within 6 to 12 hours of confinement with the head elevated.. Aust Vet J 1995;72:45-50.
  2. Raidal SL, Love DN, Bailey GD. Effects of posture and accumulated airway secretions on tracheal mucociliary transport in the horse.. Aust Vet J 1996;73:45-49.
  3. Allano M, Labrecque O, Batista ER. Influence of short distance transportation on tracheal bacterial content and lower airway cytology in horses.. Vet J 2016;214:47-49.
  4. Padalino B, Hall E, Raidal S. Health problems and risk factors associated with long haul transport of horses in Australia.. Animals 2015;5(4):1296-1310.
  5. Tateo A, Padalino B, Boccaccio M, Maggiolino A, Centoducati P. Transport stress in horses: effects of two different distances.. J Vet Behav Clin Appl Res 2012;7:33-42.
  6. Austin SM, Foreman JH, Hungerford LL. Case-control study of risk factors for development of pleuropneumonia in horses.. J Am Vet Med Assoc 1995;207:325-328.
  7. Copas V. Diagnosis and treatment of equine pleuropneumonia.. Practice 2011;33:155-162.
  8. Feary DJ, Hassel DM. Enteritis and colitis in horses.. Vet Clin N Am Equine Pract 2006;22:437-479.
  9. Stull CL, Rodiek AV. Effects of cross-tying horses during 24 h of road transport.. Equine Vet J 2002;34(6):550-555.
  10. Waran NK. The behaviour of horses during and after transport by road.. Equine Vet Ed 1993;5:129-132.
  11. Miller AB, Harris PA, Barker VD, Adams AA. Short-term transport stress and supplementation alter immune function in aged horses.. PloS One 2021;16(8):e0254139.
  12. Hobo S, Oikawa M, Kuwano A. Effect of transportation on the composition of bronchoalveolar lavage fluid obtained from horses.. Am J Vet Res 1997;58(5):531-534.
  13. Smith FL, Watson JL, Spier SJ. Frequency of shedding of respiratory pathogens in horses recently imported to the United States.. J Vet Intern Med 2018;32(4):1436-1441.
  14. Raidal SL, Taplin RH, Bailey GD. Antibiotic prophylaxis of lower respiratory tract contamination in horses confined with head elevation for 24 or 48 hours.. Aust Vet J 1997;75(2):126-131.
  15. Webb WR. Clinical evaluation of a mucolytic agent, acetyl-cysteine.. J Thorac Cardiovasc Surg 1962;44:330-343.
  16. Sadowska AM, Verbraecken J, Darquennes K, de Backer WA. Role of N-acetylcysteine in the management of COPD.. Int J Chron Obstruct Pulmon Dis 2006;1:425-434.
  17. Radomska-Leoeniewska DM, Skopińska-Różewska E, Jankowska-Steifer E. N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients.. Pharmacol Rep 2010;62:131-138.
  18. Maher TM, Wells AU, Laurent GJ. Idiopathic pulmonary fibrosis: multiple causes and multiple mechanism.. Eur Respir J 2007;30:835-839.
  19. Van Schooten FJ, Besaratinia A, De Flora S. Effects of oral administration of N-acetyl-L-cysteine: a multibiomarker study in smokers.. Cancer Epidemiol Biomarkers Prev 2002;11:167-175.
  20. Zuin R, Palamidese A, Negrin R, Catozzo L, Scarda A, Balbinot M. High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease.. Clin Drug Investig 2005;25:401-408.
  21. Oikawa M, Takagi S, Anzai R, Yoshikawa H, Yoshikawa T. Pathology of equine respiratory disease occurring in association with transport.. J Comp Pathol 1995;113:29-43.
  22. Chiesa OA, Cuenca R, Mayayo E. Cytological and microbiological findings in guttural pouch lavages of clinically normal horses with head restraint.. Aust Vet J 2002;80(4):234-238.
  23. Witte TS, Melkus E, Walter I. Effects of oral treatment with N-acetylcysteine on the viscosity of intrauterine mucus and endometrial function in estrous mares.. Theriogenology 2012;78(6):1199-1208.
  24. Henry ML, Velez-Irizarry D, Pagan JD, Sordillo L, Gandy J, Valberg SJ. The impact of n-acetyl cysteine and coenzyme Q10 supplementation on skeletal muscle antioxidants and proteome in fit Thoroughbred horses.. Antioxidants 2021;10(11):1739.
  25. Hutter D, Greene JJ. Influence of the cellular redox state on NF-κB-regulated gene expression.. J Cell Physiol 2000;183(1):45-52.
  26. Lappas M, Permezel M, Rice GE. N-acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro.. J Clin Endocrinol Metab 2003;88(4):1723-1729.
  27. Radomska-Lesniewska DM, Sadowska AM, Van Overveld FJ. Influence of N-acetylcysteine on ICAM-1 expression and il-8 release from endothelial and epithelial cells.. J Physiol Pharmacol 2007;57(S4):325-334.
  28. Palacio JR, Markert UR, Martínez P. Anti-inflammatory properties of N-acetylcysteine on lipopolysaccharide-activated macrophages.. J Inflamm Res 2011;60:695-704.
  29. Gerber V, Straub R, Marti E. Endoscopic scoring of mucus quantity and quality: observer and horse variance and relationship to inflammation, mucus viscoelasticity and volume.. Equine Vet J 2004;36(7):576-582.

Citations

This article has been cited 1 times.
  1. Rösch S, Oechtering GU. Primary and Secondary Sinonasal Aspergillosis in Dogs. Animals (Basel) 2025 Oct 1;15(19).
    doi: 10.3390/ani15192880pubmed: 41096475google scholar: lookup